# TesoRx Pharma, LLC: Form D filings

TesoRx Pharma, LLC, a pharmaceuticals company in Menlo Park, CA, filed 5 Form D notices with the SEC between 2012 and 2019. The latest, on May 3, 2019, reports $289,000 sold of a $5.2 million offering to 2 investors.

Find out what TesoRx Pharma, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TesoRx%20Pharma%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TesoRx%20Pharma%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftesorx-pharma-llc-1554258)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TesoRx%20Pharma%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TesoRx%20Pharma%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftesorx-pharma-llc-1554258)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 325 SHARON PARK DRIVE, SUITE 739, Menlo Park, CA, 94025
- Phone: (650) 490-4820
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1554258

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 3, 2019 | New notice | $5,200,000 | $289,000 | $4,911,000 | 2 | Apr 19, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554258/000155425819000001/0001554258-19-000001-index.htm) |
| Jul 13, 2016 | New notice | $5,000,000 | $697,532 | $4,302,468 | 8 | Jul 12, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554258/000155425816000002/0001554258-16-000002-index.htm) |
| May 15, 2014 | New notice | $10,068,256 | $1,985,000 | $8,083,256 | 3 | May 8, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554258/000155425814000001/0001554258-14-000001-index.htm) |
| Jul 30, 2013 | New notice | $5,000,000 | $3,922,979 | $1,077,021 | 9 | Jul 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554258/000155425813000001/0001554258-13-000001-index.htm) |
| Jul 16, 2012 | New notice | $6,597,654 | $5,922,610 | $675,044 | 19 | Jun 26, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1554258/000155425812000001/0001554258-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Willem A Robberts | Executive Officer, Director |  |
| Ramachandran Thirucote | Executive Officer, Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Apr 29, 2019](https://specstream.ai/data/form-d/week/2019-04-29) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TesoRx Pharma, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).